COVID-19 PNEUMONIA; CONFIRMED CLINICAL VACCINATION FAILURE; EMPHYSEMA; NODULE ON HIS LUNG; BRAIN FOG; BACTERIAL PNEUMONIA; This spontaneous report received from a consumer concerned a 55 year old  adult male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-smoker, alcohol user (couple of beers per day), penicillin allergy, drug allergy (sulpha drugs), seizure since 1986 which was confirmed by an neurologist and high blood pressure and he takes medications for these conditions and the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286 expiry: UNKNOWN) dose was not reported,1 total, administered on 16-JUL-2021 to left arm for covid-19 prophylaxis. Age at time of vaccination 55 years old. No concomitant medications were reported.  On an unspecified date in DEC-2021, the patient contracted covid which was confirmed at home by home test kit (COVID-19 rapid POC test Positive) which was resulted to confirmed clinical vaccination failure. The primary care physician (PCP) told him to have rest and take fluids, zinc and vitamin C (ascorbic acid). Then the patient's condition got worse and he was hospitalized on 25-DEC-2021 and in the hospital he was diagnosed with covid pneumonia (covid-19 pneumonia) and received monoclonal antibody treatment. On an unspecified date, the patient experienced bacterial pneumonia, He had an lung scan and a doppler for his leg for blood clots for which results were not reported. The physician prescribed him an antibiotics and put him on oxygen (2 liters every night) as his oxygen levels were dropping at night till at the time of reporting. The patient had next follow up scheduled with the physician on JAN-2023. The patient later diagnosed with emphysema and a nodule on his lung (not quite sure which lung). He was also experiencing general fatigue and brain fog. The patient was on albuterol (salbutamol) for his breathing as his rescue medication and also on trelegy (fluticasone furoate/umeclidinium bromide/vilanterol trifenatate) for his lungs. The duration of the hospitalization was not reported. The physician want him to get the CT (computed tomography) scan for which he cannot afford. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bacterial pneumonia, and the outcome of confirmed clinical vaccination failure, emphysema, nodule on his lung, covid-19 pneumonia and brain fog was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This case was associated with a product quality complaint: 90000263696. Sender's Comments: V0: 20221238570-Covid 19 pnuemonia. The event is deemed to be scientifically implausible, i.e., there is scientific evidence against a drug/event relationship; AND there is no known class effect. Therefore, this event is considered inconsistent with vaccine administration.   20221238570-Bacterial pnuemonia. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.   20221238570-confirmed clinical vaccination failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.